201 related articles for article (PubMed ID: 9987697)
1. The pharmacodynamics of sumatriptan in nitroglycerin-induced headache.
Fullerton T; Komorowski-Swiatek D; Forrest A; Gengo FM
J Clin Pharmacol; 1999 Jan; 39(1):17-29. PubMed ID: 9987697
[TBL] [Abstract][Full Text] [Related]
2. Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs.
Iversen HK; Olesen J
Cephalalgia; 1996 Oct; 16(6):412-8. PubMed ID: 8902249
[TBL] [Abstract][Full Text] [Related]
3. Sumatriptan. An updated review of its use in migraine.
Perry CM; Markham A
Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601
[TBL] [Abstract][Full Text] [Related]
4. Cerebral and ocular hemodynamic effects of sumatriptan in the nitroglycerin headache model.
Schmetterer L; Wolzt M; Krejcy K; Graselli U; Findl O; Eichler HG; Singer EA
Clin Pharmacol Ther; 1996 Aug; 60(2):199-205. PubMed ID: 8823238
[TBL] [Abstract][Full Text] [Related]
5. Sumatriptan and cerebral blood flow velocity changes during migraine attacks.
Totaro R; De Matteis G; Marini C; Baldassarre M; Carolei A
Headache; 1997; 37(10):635-9. PubMed ID: 9439084
[TBL] [Abstract][Full Text] [Related]
6. Sumatriptan Does Not Antagonize CGRP-Induced Symptoms in Healthy Volunteers.
Falkenberg K; Rønde Bjerg H; Yamani N; Olesen J
Headache; 2020 Apr; 60(4):665-676. PubMed ID: 31944310
[TBL] [Abstract][Full Text] [Related]
7. Nitroglycerin enhances the propagation of cortical spreading depression: comparative studies with sumatriptan and novel kynurenic acid analogues.
Knapp L; Szita B; Kocsis K; Vécsei L; Toldi J
Drug Des Devel Ther; 2017; 11():27-34. PubMed ID: 28053504
[TBL] [Abstract][Full Text] [Related]
8. Towards a pragmatic human migraine model for drug testing: 2. Isosorbide-5-mononitrate in healthy individuals.
Hansen EK; Olesen J
Cephalalgia; 2017 Jan; 37(1):11-19. PubMed ID: 26924839
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and pharmacodynamic profiles of sumatriptan in migraine patients with headache recurrence or no response.
Visser WH; Burggraaf J; Muller LM; Schoemaker RC; Fowler PA; Cohen AF; Ferrari MD
Clin Pharmacol Ther; 1996 Oct; 60(4):452-60. PubMed ID: 8873693
[TBL] [Abstract][Full Text] [Related]
10. Middle cerebral artery velocity correlates with nitroglycerin-induced headache onset.
Tegeler CH; Davidai G; Gengo FM; Knappertz VA; Troost BT; Gabriel H; Davis RL
J Neuroimaging; 1996 Apr; 6(2):81-6. PubMed ID: 8634492
[TBL] [Abstract][Full Text] [Related]
11. Transcranial Doppler in migraine attacks before and after treatment with oral zolmitriptan or sumatriptan.
Thomaides T; Karagounakis D; Spantideas A; Katelanis S
Headache; 2003 Jan; 43(1):54-8. PubMed ID: 12864759
[TBL] [Abstract][Full Text] [Related]
12. Transcranial Doppler measurements in migraine and nitroglycerin headache.
Kassab MY; Majid A; Bakhtar O; Farooq MU; Patel K; Bednarczyk EM
J Headache Pain; 2007 Oct; 8(5):289-93. PubMed ID: 17955171
[TBL] [Abstract][Full Text] [Related]
13. Mixed effect modeling of sumatriptan pharmacokinetics during drug development: II. From healthy subjects to phase 2 dose ranging in patients.
Cosson VF; Fuseau E
J Pharmacokinet Biopharm; 1999 Apr; 27(2):149-71. PubMed ID: 10567953
[TBL] [Abstract][Full Text] [Related]
14. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.
Goadsby PJ; Ferrari MD; Olesen J; Stovner LJ; Senard JM; Jackson NC; Poole PH
Neurology; 2000 Jan; 54(1):156-63. PubMed ID: 10636142
[TBL] [Abstract][Full Text] [Related]
15. Clinically relevant behavioral endpoints in a recurrent nitroglycerin migraine model in rats.
Sufka KJ; Staszko SM; Johnson AP; Davis ME; Davis RE; Smitherman TA
J Headache Pain; 2016; 17():40. PubMed ID: 27093871
[TBL] [Abstract][Full Text] [Related]
16. Toward a pragmatic migraine model for drug testing: I. Cilostazol in healthy volunteers.
Hansen EK; Guo S; Ashina M; Olesen J
Cephalalgia; 2016 Feb; 36(2):172-8. PubMed ID: 25934317
[TBL] [Abstract][Full Text] [Related]
17. Duality in response of intracranial vessels to nitroglycerin revealed in rats by imaging photoplethysmography.
Sokolov AY; Volynsky MA; Potapenko AV; Iurkova PM; Zaytsev VV; Nippolainen E; Kamshilin AA
Sci Rep; 2023 Jul; 13(1):11928. PubMed ID: 37488233
[TBL] [Abstract][Full Text] [Related]
18. Sumatriptan fast-disintegrating/rapid-release tablets.
Moen MD; Keating GM
Drugs; 2006; 66(6):883-90. PubMed ID: 16706565
[TBL] [Abstract][Full Text] [Related]
19. Experimental headache in humans.
Iversen HK
Cephalalgia; 1995; 15(4):281-7. PubMed ID: 7585924
[TBL] [Abstract][Full Text] [Related]
20. Sumatriptan for the treatment of undifferentiated primary headaches in the ED.
Miner JR; Smith SW; Moore J; Biros M
Am J Emerg Med; 2007 Jan; 25(1):60-4. PubMed ID: 17157685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
